Ocumetics Technology Corp. (OTCFF)
Market Cap | 34.14M |
Revenue (ttm) | n/a |
Net Income (ttm) | -2.28M |
Shares Out | n/a |
EPS (ttm) | -0.02 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 45,000 |
Average Volume | 25,484 |
Open | 0.2970 |
Previous Close | 0.2970 |
Day's Range | 0.2970 - 0.2970 |
52-Week Range | 0.1872 - 0.3555 |
Beta | -0.72 |
RSI | 63.03 |
Earnings Date | Aug 28, 2025 |
About Ocumetics Technology
Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. The company develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed changed its name to Ocumetics Technology Corp. in August 2021. Ocumetics Technology Corp. was founded in 2012 and is headquartered in Calgary, Canada. [Read more]
News

Ocumetics Completes Staff Training for First-In-Human Clinical Study of Accommodating Intraocular Lens
Calgary, Alberta – TheNewswire - July 9, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is please...

Ocumetics Completes Virtual Site Initiation for First-In-Human Clinical Study of Accommodating Intraocular Lens
Calgary, Alberta – TheNewswire - June 26, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleas...

First-In-Human Study of Accommodating Intraocular Lens Set to Begin June 26, 2025
Calgary, Alberta – TheNewswire - June 24, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleas...

Ocumetics Announces Private Placement
Calgary, Alberta – TheNewswire - June 4, 2025 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it proposes to complete a privat...

Ocumetics Targets June 26, 2025 for Commencement of its First in Human Study
Calgary, Alberta - TheNewswire - – June 3, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is plea...

Ocumetics Announces Mexico City as Site for its First in Human Study
Calgary, Alberta – TheNewswire - June 2, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is please...

Ocumetics Clinical Study Protocol Submission and Site Initiation on Schedule for Summer 2025
Calgary, Alberta – TheNewswire - May 22, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is please...

Ocumetics Completes Manufacturing of Lenses to be used in First-in-Human Study
Calgary, Alberta – TheNewswire - May 14, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is please...

Ocumetics Announces Lens Design Freeze for First-in-Human Study
Calgary, Alberta – TheNewswire - May 12 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased ...

Ocumetics Achieves Key Milestone: Laboratory Testing Confirms Accommodative Power Target was Successfully Achieved in Preparation for First-in-Human Trials
Calgary, Alberta – TheNewswire - May 8, 2025 - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased ...

Ocumetics Announces Corporate Changes
Calgary, Alberta – TheNewswire - May 1, 2025 - Ocumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) (the “ Corporation ” or “ Ocumetics ”) announces that Mr. Dayton Marks has resigned as ...

Ocumetics Announces Completion of Major Milestones First-In-Human Surgery Planned for Summer 2025
Calgary, Alberta – TheNewswire - April 22, 2025 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is plea...

Ocumetics Engages Independent Trading Group as Market Maker
Calgary, Alberta – TheNewswire - March 24, 2025 – Ocumetics Technology Corp. (“ Ocumetics ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce ...

Ocumetics Announces Appointment of Michael L. Edwards to Board of Directors
Calgary, Alberta – TheNewswire - March 11, 2025. Ocumetics Technology Corp. (“ Ocumetics” or the “Corporation”) ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced ophthalmic technology, ...